| | 106635-81-8 Basic information More.. |
| Product Name: | TAFENOQUINE SUCCINATE | | Synonyms: | WR-238605;Butanedioic acid, compd. with N(sup 4)-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1);Wr238605 succinate;Tafenoquine Succinate;N-[2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine;SB-252263;SB 252263AX;8-[(4-Amino-1-methylbutyl)amino]-2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinoline succinate | | CAS: | 106635-81-8 | | MF: | C28H34F3N3O7 | | MW: | 581.5806696 | | EINECS: | | | Mol File: | 106635-81-8.mol |  |
Use
Tafenoquine succinate is a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the preven tion and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase.
- Tafenoquine succinate
-
- US $0.00-0.00 / g
- 2025-04-02
- CAS:106635-81-8
- Min. Order: 1g
- Purity: 98.0%
- Supply Ability: 1kg/month
|
|
106635-81-8
Recommend Suppliers |
|